Higher graft cell dose does not influence development of acute or chronic GVHD in haploidentical transplantation using post-transplantation cyclophosphamide.
Mariam T NawasAnnie ImBrian C ShafferPublished in: Blood advances (2023)
Keyphrases
- cell therapy
- liver failure
- single cell
- stem cell transplantation
- low dose
- drug induced
- high dose
- bone marrow
- respiratory failure
- stem cells
- peripheral blood
- aortic dissection
- allogeneic hematopoietic stem cell transplantation
- mesenchymal stem cells
- hepatitis b virus
- intensive care unit
- cord blood
- extracorporeal membrane oxygenation